The fourth call is open from 1 April 2019 – 1st June 2019. It covers 3 modules:
- M6 – CyTOF (Cytometry by time‐of‐flight) conducted at CEA, Fontenay-aux-Roses, France (19-20 September 2019)
- M7 – Flow Cytometry organized also by CEA, Fontenay-aux-Roses, France (18-19 September 2019)
- M9 – Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies, organized by VFI together with Merck at Merck/M Lab permises in Molsheim, France (10-11 September 2019)
Participants will be selected by a course selection panel.
The course is offered free of charge. However selected applicants will have to cover their own travel and visa expenses and accommodation (excluding M9, where accommodation will be provided by organizers).
Candidates working in a European Union Member State or Associated Member State as well as candidates from other countries who are working in vaccine development projects funded by the European Commission (EC) or European and Developing Countries Clinical trial Partnership (EDCTP) are eligible to apply. Other candidates can also apply, but priority will be given to the groups mentioned above.
For more information about the training modules offered by TRANSVAC, the eligibility criteria and the application process, please visit: www.transvac.org
If you have any specific questions, you can contact the project management team at: firstname.lastname@example.org